Imprimis Pharmaceuticals

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a rapidly-growing ophthalmology-focused pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications that offer competitive advantages and serve unmet needs in the marketplace.  The company’s unique business model increases patient access and affordability to many critical medicines while also increasing the level of convenience and compliance for providers and their patients.  Headquartered in San Diego, California, Imprimis owns and operates three dispensing facilities located in California, New Jersey and Pennsylvania.  For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com.